Literature DB >> 9420056

Amino acid variation in the GyrA subunit of bacteria potentially associated with natural resistance to fluoroquinolone antibiotics.

B Waters1, J Davies.   

Abstract

In studies of genetic diversity in natural microbial populations, we have analyzed nucleotide sequences in the quinolone resistance-determining region of the bacterial gyrA gene in ciprofloxacin-resistant and nonselected soil bacteria obtained from the environment. It is apparent that this sequence is highly variable, and resistance to fluoroquinolone antibiotics occurring in environmental populations of bacteria is due at least in part to natural sequence variation in this domain. We suggest that the development of new antimicrobial agents, including completely synthetic antimicrobials such as the fluoroquinolones, should incorporate the analysis of resistance mechanisms among microbes in natural environments; these studies could predict potential mechanisms of resistance to be encountered in subsequent clinical use of the agents and would guide chemical modification designed to evade resistance development.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9420056      PMCID: PMC164206     

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  20 in total

1.  Basic local alignment search tool.

Authors:  S F Altschul; W Gish; W Miller; E W Myers; D J Lipman
Journal:  J Mol Biol       Date:  1990-10-05       Impact factor: 5.469

2.  The Ribosomal Database Project.

Authors:  G J Olsen; R Overbeek; N Larsen; T L Marsh; M J McCaughey; M A Maciukenas; W M Kuan; T J Macke; Y Xing; C R Woese
Journal:  Nucleic Acids Res       Date:  1992-05-11       Impact factor: 16.971

Review 3.  Bacterial diversity based on type II DNA topoisomerase genes.

Authors:  W M Huang
Journal:  Annu Rev Genet       Date:  1996       Impact factor: 16.830

4.  DNA gyrase gyrA mutations in ciprofloxacin-resistant strains of Staphylococcus aureus: close similarity with quinolone resistance mutations in Escherichia coli.

Authors:  S Sreedharan; M Oram; B Jensen; L R Peterson; L M Fisher
Journal:  J Bacteriol       Date:  1990-12       Impact factor: 3.490

5.  A novel, double mutation in DNA gyrase A of Escherichia coli conferring resistance to quinolone antibiotics.

Authors:  Q C Truong; J C Nguyen Van; D Shlaes; L Gutmann; N J Moreau
Journal:  Antimicrob Agents Chemother       Date:  1997-01       Impact factor: 5.191

6.  Quinolone resistance-determining region in the DNA gyrase gyrB gene of Escherichia coli.

Authors:  H Yoshida; M Bogaki; M Nakamura; L M Yamanaka; S Nakamura
Journal:  Antimicrob Agents Chemother       Date:  1991-08       Impact factor: 5.191

Review 7.  DNA gyrase: structure and function.

Authors:  R J Reece; A Maxwell
Journal:  Crit Rev Biochem Mol Biol       Date:  1991       Impact factor: 8.250

8.  Nalidixic acid resistance: a second genetic character involved in DNA gyrase activity.

Authors:  M Gellert; K Mizuuchi; M H O'Dea; T Itoh; J I Tomizawa
Journal:  Proc Natl Acad Sci U S A       Date:  1977-11       Impact factor: 11.205

9.  Quinolone resistance mutations in the DNA gyrase gyrA and gyrB genes of Staphylococcus aureus.

Authors:  H Ito; H Yoshida; M Bogaki-Shonai; T Niga; H Hattori; S Nakamura
Journal:  Antimicrob Agents Chemother       Date:  1994-09       Impact factor: 5.191

10.  Quinolone-resistant mutations of the gyrA gene of Escherichia coli.

Authors:  H Yoshida; T Kojima; J Yamagishi; S Nakamura
Journal:  Mol Gen Genet       Date:  1988-01
View more
  13 in total

1.  Alterations in GyrA and ParC associated with fluoroquinolone resistance in Enterococcus faecium.

Authors:  N A el Amin; S Jalal; B Wretlind
Journal:  Antimicrob Agents Chemother       Date:  1999-04       Impact factor: 5.191

2.  Environmental metabolites of fluoroquinolones: synthesis, fractionation and toxicological assessment of some biologically active metabolites of ciprofloxacin.

Authors:  Gareth Lewis; Albert Juhasz; Euan Smith
Journal:  Environ Sci Pollut Res Int       Date:  2012-02-04       Impact factor: 4.223

3.  Detection of antibacterial-like activity on a silica surface: fluoroquinolones and their environmental metabolites.

Authors:  Gareth Lewis; Albert Juhasz; Euan Smith
Journal:  Environ Sci Pollut Res Int       Date:  2012-02-05       Impact factor: 4.223

4.  Broad-spectrum antibiotic activity of the arylomycin natural products is masked by natural target mutations.

Authors:  Peter A Smith; Tucker C Roberts; Floyd E Romesberg
Journal:  Chem Biol       Date:  2010-11-24

5.  Antibiotic resistance in bacteria isolated from the deep terrestrial subsurface.

Authors:  Mindy G Brown; David L Balkwill
Journal:  Microb Ecol       Date:  2008-08-02       Impact factor: 4.552

Review 6.  Call of the wild: antibiotic resistance genes in natural environments.

Authors:  Heather K Allen; Justin Donato; Helena Huimi Wang; Karen A Cloud-Hansen; Julian Davies; Jo Handelsman
Journal:  Nat Rev Microbiol       Date:  2010-03-01       Impact factor: 60.633

7.  DNA gyrase-mediated natural resistance to fluoroquinolones in Ehrlichia spp.

Authors:  M Maurin; C Abergel; D Raoult
Journal:  Antimicrob Agents Chemother       Date:  2001-07       Impact factor: 5.191

8.  Molecular evaluation of antibiotic susceptibility: Tropheryma whipplei paradigm.

Authors:  F Masselot; A Boulos; M Maurin; J M Rolain; D Raoult
Journal:  Antimicrob Agents Chemother       Date:  2003-05       Impact factor: 5.191

9.  Agricultural use of antibiotics and the evolution and transfer of antibiotic-resistant bacteria.

Authors:  G G Khachatourians
Journal:  CMAJ       Date:  1998-11-03       Impact factor: 8.262

10.  Mutagenesis in the alpha3alpha4 GyrA helix and in the Toprim domain of GyrB refines the contribution of Mycobacterium tuberculosis DNA gyrase to intrinsic resistance to quinolones.

Authors:  Stéphanie Matrat; Alexandra Aubry; Claudine Mayer; Vincent Jarlier; Emmanuelle Cambau
Journal:  Antimicrob Agents Chemother       Date:  2008-04-21       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.